Medicinova (MNOV) Q1 2026 Earnings
MNOV·Reported May 15, 2026·After market close
Medicinova reported Q1 2026 revenue of $187.0K. Diluted EPS came in at $-0.05 (+16.7% YoY), beat the $-0.06 consensus by $0.01.
Revenue
$187.0Kmet estimate
Consensus: $187.0KDiluted EPS
$-0.05beat by $0.01
Consensus: $-0.06
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about Medicinova's Q1 2026 earnings report.
Medicinova (MNOV) reported Q1 2026 earnings on May 15, 2026 after market close.
Medicinova reported revenue of $187.0K and diluted EPS of $-0.05 for Q1 2026.
Revenue beat the consensus estimate of $187.0K by -. EPS beat the consensus estimate of $-0.06 by $0.01.
Compared to the same quarter a year prior, diluted EPS grew 16.7% from $-0.06.
You can read the 10-Q periodic report (0001193125-26-224066) directly on SEC EDGAR. The filing index links above go to sec.gov.